PDEI + 5‐ARI vs 5‐ARI alone
IPSS‐total score
2 findings from 1 review
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes onlyno estimate extracted1 study · 695 participantsModerate
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes onlyno estimate extracted1 study · 695 participantsModerate